SynthesisBMC cancer2024

Efficacy and safety of Zolbetuximab plus chemotherapy for advanced CLDN18.2-positive gastric or gastro-oesophageal adenocarcinoma: a meta-analysis of randomized clinical trials.

Francisco Cezar Aquino de Moraes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.